INDV
Indivior Pharmaceuticals, Inc.
Stock
$35.71+0.33 (+0.93%)Close Oct 2, 2026
- Net income, 2025
- $210M
- YoY, 2025
- +2,900.0%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $210M | +2,900.0% |
| 2024 | $7.0M | — |
| 2023 | −$126M | — |
| 2022 | −$42M | — |
| 2021 | $205M | — |